BioMedix® Earns Five 2012 Aster Awards for Excellence in Healthcare Marketing

ST. PAUL, MN — May 9, 2012 — BioMedix received one Gold and four Silver awards in the 2012 Aster Awards healthcare marketing competition. Award-winning materials included the company’s webinar series, tradeshow display advertising and specialized marketing and educational tools. BioMedix has won a total of 18 Aster Awards over the past three years.

With a near-perfect score in the top 5% of the competition, BioMedix won a Gold award for its 2011 webinar series. Webinars in the series featured important topics in healthcare presented by experts in the field. The presentations provided information and tips on the adoption of Electronic Health Records,

HIPAA compliance and marketing in-office vascular testing. This successful webinar series has continued into 2012 with a focus on Meaningful Use, an especially pertinent issue-as incentive deadlines loom.

The Aster Awards Program is one of the largest national contests of its kind. This elite medical marketing competition awards healthcare professionals for excellence in advertising and marketing. The program is hosted by Marketing Healthcare Today magazine and Creative Images, Inc.

“Although our nation has been challenged economically, the talent of healthcare marketing professionals seems to be at an all-time high. The 2012 Aster Awards program contained some of the best advertising arguably in the world. The judge’s expectations were again surpassed,” said Melinda Lucas, Aster Awards Program Coordinator.

The Aster Awards receive approximately 3,000 entries per year, each judged by a panel of marketing professionals. Entries are judged on their creativity, layout and design, functionality, message effectiveness, production quality and overall appeal, and must score at least in the top 16% to receive an award.

“It is an honor to be recognized by the Aster Awards for the third year in a row for our marketing initiatives and educational materials,” said Mike Lobinsky, BioMedix Vice President of Sales and Marketing, “We are proud to create award-winning work that keeps our clients informed and supports their community-based collaborative healthcare networks.”

All winners are posted on the Aster Awards website (www. AsterAwards.com) and published in Marketing Healthcare Today, a national healthcare marketing magazine.

BioMedix® Partners with WesternU to Promote Amputation Prevention

ST. PAUL, MN — May 15, 2012 — BioMedix, a leading provider of collaborative healthcare IT solutions, has joined with Western University of Health Sciences (WesternU) to promote amputation prevention through awareness and early detection of Peripheral Artery Disease (P.A.D.).

Through an educational grant from BioMedix, the WesternU College of Podiatric Medicine will have access to BioMedix PADnet ™, a user-friendly test for the early detection of P.A.D. In just 15 to 20 minutes the non-invasive PADnet Arterial test helps identify obstructive disease and determine whether medical or surgical treatment is necessary.

“Our partnership with Bio- Medix and the use of PADnet technology will support the success of a new Amputation Prevention and Wound Care Center at WesternU,” said Jonathan Labovitz, DPM, FACFAS. Dr. Labovitz is associate professor and department chair of Medicine, Surgery and Biomechanics in the College of Podiatric Medicine and Medical Director of the Foot & Ankle Center at WesternU. “The Center will be an important addition to the WesternU campus that will allow us to appropriately diagnose P.A.D. and improve outcomes through decreased amputations and improved quality of life.”

Diabetic patients make up a large number of those treated at the Foot & Ankle Center at WesternU. Diabetes increases the risk of P.A.D., and diabetic patients with P.A.D. are more likely to undergo a major amputation than non-diabetics. The introduction of the Amputation Prevention and Wound Care Center, along with the use of PADnet, will provide a greater opportunity for diabetic patients to be tested for P.A.D. and treated early, limiting the progression of disease and reducing risk of amputation.

“Limb loss is an avoidable outcome of P.A.D. that has a significant impact on patient health and quality of life,” said John Romans, BioMedix President & CEO, “We are proud to support

the WesternU podiatric medicine program and further our joint mission to promote enhanced care through community-based physician collaboration.”

About BioMedix

BioMedix is a leader in healthcare IT designed to build and support community-based collaborative healthcare networks. BioMedix solutions coordinate the identification, treatment and management of patients with vascular disease while optimizing provider resources with cloud- and premise-based tools and integrated services. For more information about BioMedix, call 877- 854-0014 or visit www.BioMedix.com. For more information about PADnet, visit www.PADnet.com.

About Western University of Health Sciences Western University of Health Sciences (www.westernu.edu), located in Pomona, Calif. and Lebanon, Ore., is an independent nonprofit health professions university, conferring degrees in biomedical sciences, dental medicine, health sciences, medical sciences, nursing, optometry, osteopathic medicine, pharmacy, physical therapy, physician assistant studies, podiatric medicine and veterinary medicine.

Doff & Donner now available to US Medical Retailers, Caregivers and Patients!

A new superior donning device for compression garments is now available in the US! It’s called the Doff & Donner and it makes it easier than ever to put on and take off compression socks and stockings, and even arm-sleeves!

Let´s face it, people come in all shapes and sizes and with the large number of compression garment variations, putting them on can be quite a daily challenge for you or even a family member or caregiver. Due to these issues, the donning of compression garments has been a problem since the creation of the garments. Not everyone has the strength to pull on the very tight garments, nor do they always have the help they may need to do so. The Doff & Donner was invented to resolve all of these issues. This phenomenal tool was developed to bridge the gap between the prescribed need of the patient to wear the garments and the ability of the patient to be compliant with the doctors´ orders.

The Doff & Donner has the ability to Don a garment over any size or shape of leg, as well as over wet, slippery with lotion, or bandaged legs with no struggle at all. The efficient and versatile Donning performance of the Doff & Donner is only half of it. This device also uses the same conveying action to safely and effortlessly Doff the garments from the leg and store them prepared for the next fitting. The Doff & Donner’s conveying action also helps to increase the longevity of the garment by limiting the wear and tear created by the tugging of conventional Donning. For video demos, please click or copy and paste the following links:

So easy a 6-year old can do it:

www.youtube.com/watch?v=SeEWGZpRS0A

Donning over bandages:

www.youtube.com/watch?v=n7FuNnTJS9E

Wet Legs-Not an issue:

www.youtube.com/watch?v=o75S9R0VTjg

Center for Venous Disease Varicose Vein Treatment Centers Announce Completion of American Board of Phlebology Certification

The Center for Venous Disease® would like to announce and congratulate our Medical Directors for completing the American Board of Phlebology (ABPh) certification requirements (americanboardofphlebology. org) related to venous disease treatment. The American Board of Phlebology was established in 2007. The primary goals of the ABPh designation were to: Improve the standards of medical practitioners and the quality of patient care related to the treatment of venous disease (varicose vein treatment). Standards were established for training and education, Award Certification, ongoing maintenance and continuing education requirements. A registry of physician specialists in the practice of Phlebology was established.

“The importance of having ABPh vein specialists working with CVD cannot be understated. As a patient, you should seek out the best qualified doctor in your area for your particular medical condition. After all, you wouldn’t see a primary care physician if you needed a Heart transplant, would you? So, why would you schedule a doctor’s appointment with a non-specialist for your leg issues? That’s where the ABPh certification comes in.” - James A. Heinz, M.A.H.A.

CVD recognizes the achievements of Drs: Joseph M. Smith (Santa Fe, NM), Thomas Pester (El Paso, TX), Felice’ Bruno (El Paso, TX), Thomas Elliott (Tucson, AZ), David M. Smith (Glendale, AZ), Michael A. Herion, (Glendale, AZ) William Fulton (Gilbert, AZ), and Thomas Strawn (Phoenix, AZ). They have all demonstrated through peer review, course review, and testing standards of their advanced educational experience related to varicose vein, spider veins, venous ulcers, skin breakdown, swollen legs, restless legs, wound care, and painful throbbing legs.

It is a CVD® mandate that all CVD Medical Directors have the ABPh certification regardless of their other Board Certifications. In most cases, CVD doctors are triple-board certified and have

surgical training with ultrasound experience.

CVD owns and operates Total Vein Care centers in Arizona, New Mexico, and Texas. CVD continues to grow posting increases over prior year in billed charges and a 26% increase in revenue through May 2012. CVD is recognized at the National Level as one of the premier vein care treatment centers in the U.S.

CVD utilizes the ClosureFAST™ radio-frequency catheter system from Covidien Vascular Therapies. This technology has been clinically proven to have less post-procedure pain and bruising as compared to Endovenous Laser (EVLT or EVL) procedures. For more information related to varicose vein treatment, please visit reTHINK Varicose Veins at www.rethinkvaricoseveins.com or our patient screening website at www.veinscreening.com.

The prevalence of venous disease in the United States is 30- 50 million people. More than 200 million people have access to the minimally invasive-technology as a covered benefit by the insurance industry due to long-term clinical results and patient satisfaction. CVD recommends seeking treatment from qualified doctors specializing in venous disease (ABPh Certification). Please visit www.healthylegs.net for more information about our company, locations, services provided, insurance questions, and doctor biographies.

Please ask your CVD doctor about our book titled “Varicose Veins... A Patient’s Reference” written by our Founder. The Center for Venous Disease supports the American College of Phlebology and American College of Phlebology Foundation. Mr. Heinz was a former board member of the ACPF, is the Founder of CVD, and has earned a Masters Degree in Healthcare Administration. His healthcare experience spans a 30 year career. The Center for Venous Disease is privately held with locations in the Southwest USA. Each office is independently owned and professionally managed by CVDJBA, LLC Management Group. Expansion plans are underway to bring our brand and doctor expertise to a city near you!

If you’re a Physician in good standing, have an interest in Phlebology, and would like more information on how to join our exclusive team, please contact Mr. Heinz. “There are many vein centers and vein institutes but there is only ONE Center for Venous Disease.”

James A. Heinz, M.A.H.A.

Founder

The Center for Venous Disease®

623-234-2542 O

623-234-2543 F

Elsevier and the Society for Vascular Surgery Announce Forthcoming Launch of Journal of Vascular Surgery: Venous and Lymphatic Disorders

Philadelphia, PA, June 7, 2012 – Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the Society for Vascular Surgery® announce the launch of a new quarterly journal, Journal of Vascular Surgery: Venous and Lymphatic Disorders. The inaugural issue will appear in January, 2013. Elsevier currently publishes the Journal of Vascular Surgery® on behalf of the Society.

“We are extremely pleased to be working with Elsevier to publish a new peer-reviewed journal specifically designed to promote venous and lymphatic health,” commented Richard Cambria, MD, President of the Society for Vascular Surgery. “A collaborative effort between the Society for Vascular Surgery and the American Venous Forum, the Journal of Vascular Surgery: Venous and Lymphatic Disorders will provide a valuable channel for the dissemination of important research and clinical information in this rapidly evolving field.”

Journal of Vascular Surgery: Venous and Lymphatic Disorders will publish high quality clinical and basic scientific research, case reports, venous images, techniques, review articles, and practice management manuscripts related to all aspects of venous disease, lymphatic disease, and wound care with an emphasis on the practicing clinician. The journal will seek to provide novel and timely information to vascular surgeons, interventionalists, phlebologists, wound care specialists, and allied health professionals who treat patients presenting with venous and lymphatic disease.

The distinguished international editorial board will be led by Anton N. Sidawy, MD, and Bruce A. Perler, MD. “Venous disease is highly prevalent and is a significant cause of morbidity and mortality,” stated Dr. Sidawy. “It is our goal to publish high-quality clinical studies, research, case reports, techniques, reviews, venous and lymphatic images, and practice management manuscripts related to all aspects of venous disease, lymphatic disease, and wound care.”

Anton N. Sidawy, MD, is Professor and Chairman of the Department of Surgery at the George Washington University in Washington, D.C. He is the Editor-in-Chief of the Journal of Vascular Surgery and Past-President of the Society for Vascular Surgery, the Society for Clinical Vascular Surgery, and the Eastern Vascular Society.

Bruce A. Perler, MD, MBA, is chief of the division of vascular surgery and professor of surgery at Johns Hopkins Medicine, Baltimore, MD. He is the Senior Editor of the Journal of Vascular Surgery and Past President of the Eastern Vascular Society and the Southern Association for Vascular Surgery

About the Society for Vascular Surgery (SVS)

The Society for Vascular Surgery® (SVS) is a not-for-profit professional medical society, composed primarily of vascular surgeons, that seeks to advance excellence and innovation in vascular health through education, advocacy, research, and public awareness. SVS is the national advocate for 3,550 specialty-trained vascular surgeons and other medical professionals who are dedicated to the prevention and cure of vascular disease. www.vascularweb.org

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include Sci- Verse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Mosby’s Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver

better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Covidien launches VNUS closure procedure for varicose veins